In breast cancer, lncRNAPVT1 has been proven to play an oncogenic function by protecting cMYC protein, which plays emerging roles in cancer stemness and resistance to chemotherapy from phosphorylation-mediated degradation [38,39]. This evidence concerns the gene MYC and breast cancer.